© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, AVITA Medical, Inc. (RCEL) shows an Average True Range (ATR) of 0.2 and an Enterprise Value of 172.2M. Its average trading volume over the past 3 months is 217.64K, indicating liquidity. These fundamental metrics provide insight into RCEL's underlying financial health and market activity.
AVITA Medical, Inc. (RCEL) technical indicators as of December 22, 2025: the SMA 20 is -2.45%, SMA 50 at -10.32%, and SMA 200 at -40.7%. The RSI 14 value is 42.7, suggesting its current momentum. These technical analysis signals help assess RCEL's price trends and potential future movements.
AVITA Medical, Inc. (RCEL) stock performance overview as of December 22, 2025: The 52-week high is $14.16 (currently -75.56% below), and the 52-week low is $3.25 (currently 6.46% above). Over the past year, RCEL's performance is -71.66%, compared to the S&P 500's 12.87% change.
According to market data, AVITA Medical, Inc. (RCEL) stock's recent performance metrics show that over the last month, RCEL is -12.41%, with a Year-to-Date (YTD) performance of -72.97%. Over the past year, the stock has seen a -71.66% change. These figures summarize RCEL's price movements across various periods, reflecting its historical returns.
According to current financial data, RCEL stock's P/E (TTM) ratio is -1.77, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for RCEL, including P/S (1.24), P/B (-7.08), and P/FCF (-2.21), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.